Cargando…

A qualitative investigation of the supportive care experiences of people living with pancreatic and oesophagogastric cancer

BACKGROUND: Pancreatic and oesophagogastric (OG) cancers have a dismal prognosis and high symptom burden, with supportive care forming an integral component of the care provided to patients. This study aimed to explore the supportive care experiences of patients and caregivers living with pancreatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Nadia N., Maharaj, Ashika, Evans, Sue, Pilgrim, Charles, Zalcberg, John, Brown, Wendy, Cashin, Paul, Croagh, Daniel, Michael, Natasha, Shapiro, Jeremy, White, Kate, Ioannou, Liane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851733/ https://www.ncbi.nlm.nih.gov/pubmed/35177079 http://dx.doi.org/10.1186/s12913-022-07625-y

Ejemplares similares

Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework
por: Maharaj, Ashika D., et al.
Publicado: (2020)

Landscape of clinical trials across the pancreatic cancer care continuum: an Australian perspective
por: Khan, Nadia N, et al.
Publicado: (2022)

Characteristics of patients diagnosed with pancreatic cancer who access palliative care: An observational study
por: Khan, Nadia N., et al.
Publicado: (2023)

The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
por: Flynn, Michael, et al.
Publicado: (2018)

The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers
por: Maharaj, Ashika D, et al.
Publicado: (2019)

The Effect of COVID-19 on Multidisciplinary Team (MDT) Outcomes for Oesophagogastric Cancer
por: Matias, Nadia, et al.
Publicado: (2023)

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
por: Tebbutt, N C, et al.
Publicado: (2010)

Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer
por: Markar, Sheraz R., et al.
Publicado: (2018)

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions
por: Bose, Katrin, et al.
Publicado: (2017)

Laparoscopic fundoplication and new aspects of neural anatomy at the oesophagogastric junction
por: Gehwolf, P., et al.
Publicado: (2020)

Laparoscopic vs. open feeding jejunostomy insertion in oesophagogastric cancer
por: Mastoridis, Sotiris, et al.
Publicado: (2021)

The impact of chemosensory and food-related changes in patients with advanced oesophagogastric cancer treated with capecitabine and oxaliplatin: a qualitative study
por: de Vries, Yfke C., et al.
Publicado: (2016)

Cardiopulmonary exercise testing as a predictor of complications in oesophagogastric cancer surgery
por: Moyes, LH, et al.
Publicado: (2013)

Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas
por: Schmidt, T, et al.
Publicado: (2014)

The Development, Application and Analysis of an Enhanced Recovery Programme for Major Oesophagogastric Resection
por: Underwood, Timothy J., et al.
Publicado: (2017)

Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study
por: Moorcraft, Sing Yu, et al.
Publicado: (2016)

Targeting Vascular Endothelial Growth Factor in Oesophagogastric Cancer: A Review of Progress to Date and Immunotherapy Combination Strategies
por: Butters, Oliver, et al.
Publicado: (2019)

The EUS molecular evaluation of pancreatic cancer: A prospective multicenter cohort trial
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2021)

Trends and variation in the management of oesophagogastric cancer patients: a population-based survey
por: Lyratzopoulos, Georgios, et al.
Publicado: (2009)

The role of the Shuttle Walking Test in predicting mortality and morbidity post oesophagogastric surgery
por: Whiting, P, et al.
Publicado: (2005)

Failure to rescue patients from early critical complications of oesophagogastric cancer surgery
por: Weledji, Elroy P., et al.
Publicado: (2016)

Endoluminal Vacuum Therapy (E-Vac): A Treatment Option in Oesophagogastric Surgery
por: Pournaras, D. J., et al.
Publicado: (2018)

Prognostic Relevance of Weight and Weight Loss during Multimodal Therapy for Oesophagogastric Tumours
por: Lorusso, Alessandro, et al.
Publicado: (2022)

Outcomes following Oesophagogastric Resections during COVID-19: A Comparative Analysis
por: Nnaji, Martin, et al.
Publicado: (2021)

Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma
por: Duque-Santana, Victor, et al.
Publicado: (2022)

Evaluation of the Oesophagogastric Cancer-Associated Microbiome: A Systematic Review and Quality Assessment
por: Vadhwana, Bhamini, et al.
Publicado: (2023)

Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers
por: Shahnam, Adel, et al.
Publicado: (2023)

Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery
por: Rahman, Saqib, et al.
Publicado: (2021)

EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy
por: Lundy, Joanne, et al.
Publicado: (2021)

Exploring the Attitudes of Health Professionals Providing Care to Patients Undergoing Treatment for Upper Gastrointestinal Cancers to Different Models of Nutrition Care Delivery: A Qualitative Investigation
por: Furness, Kate, et al.
Publicado: (2021)

A process and mechanism of action evaluation of the effect of early and intensive nutrition care, delivered via telephone or mobile application, on quality of life in people with upper gastrointestinal cancer: a study protocol
por: Furness, Kate, et al.
Publicado: (2018)

Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study
por: Turkes, Fiona, et al.
Publicado: (2022)

Laparo-endoscopic combined approach for excision of gastrointestinal stromal tumour close to the oesophagogastric junction
por: Vinnicombe, Zak, et al.
Publicado: (2015)

Clinical and manometric characteristics of patients with oesophagogastric outflow obstruction: towards a new classification
por: Triadafilopoulos, George, et al.
Publicado: (2018)

Systemic chemotherapy for gastro-oesophagogastric junction adenocarcinoma and stomach adenocarcinoma in a metastatic setting
por: Sanjeevaiah, Aravind, et al.
Publicado: (2020)

Value of individual surgeon performance metrics as quality assurance measures in oesophagogastric cancer surgery
por: Powell, A. G. M. T., et al.
Publicado: (2019)

Clinical importance of serum CEA and CA-19-9 levels in oesophagogastric junction adenocarcinomas
por: Sert, Ozlem Zeliha, et al.
Publicado: (2020)

Identifying outcomes reported in exercise interventions in oesophagogastric cancer survivors: a systematic review
por: O’Connor, Louise, et al.
Publicado: (2021)

Resection of oesophageal and oesophagogastric junction cancer liver metastases — a summary of current evidence
por: Weiss, Andreas R. R., et al.
Publicado: (2021)

Comment on: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery
por: Liu, Kai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1la0npc4ar5rtivch665bcb6mu